2252 — Shanghai MicroPort MedBot Co Share Price
- HK$16.98bn
- HK$17.05bn
- CNY257.25m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 58.16 | ||
Price to Tang. Book | 59.33 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 62.9 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -78.03% | ||
Return on Equity | -161.07% | ||
Operating Margin | -235.27% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CNYm | n/a | 2.15 | 21.6 | 104.59 | 257.25 | 640.4 | 1,233.63 | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Shanghai MicroPort MedBot Group Co Ltd is a China-based company primarily engaged in the provision of intelligent surgery total solutions. The Company’s main business is engaged in the research and development, manufacturing and sale of surgical robots. The Company’s products include Toumai Laparoscopic Surgical Robot, Skywalker Orthopedic Surgical Robot, R-one vascular intervention surgical robot, Microport Medbot and other products, covering surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice and percutaneous surgical procedures. The Company conducts its business in the domestic and overseas markets.
Directors
- Hongbin Sun NEC (46)
- Chao He PRE (36)
- Yu Liu SVP (51)
- Haiying Yu SVP (50)
- Shuxiang Li VPR (39)
- Liping Zhu DHR (43)
- Cong Fang SEC (32)
- Yin Shan Hui SEC (52)
- Chen Chen NED (37)
- Xin Sun NED (40)
- Kit Ying Lee NID (73)
- Minghua Li NID (69)
- Haisong Yao NID (47)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 11th, 2015
- Public Since
- November 2nd, 2021
- No. of Employees
- 450
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Stock Exchange of Hong Kong Limited
- Shares in Issue
- 1,006,193,831

- Address
- Room 101, Area B, Building 1, SHANGHAI, 201203
- Web
- https://www.medbotsurgical.com/
- Phone
- +86 2138954600
- Auditors
- KPMG
Upcoming Events for 2252
Half Year 2025 Shanghai MicroPort MedBot Group Co Ltd Earnings Release
Similar to 2252
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 21:58 UTC, shares in Shanghai MicroPort MedBot Co are trading at HK$17.12. This share price information is delayed by 15 minutes.
Shares in Shanghai MicroPort MedBot Co last closed at HK$17.12 and the price had moved by +32.71% over the past 365 days. In terms of relative price strength the Shanghai MicroPort MedBot Co share price has outperformed the FTSE Developed Asia Pacific Index by +34.23% over the past year.
The overall consensus recommendation for Shanghai MicroPort MedBot Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreShanghai MicroPort MedBot Co does not currently pay a dividend.
Shanghai MicroPort MedBot Co does not currently pay a dividend.
Shanghai MicroPort MedBot Co does not currently pay a dividend.
To buy shares in Shanghai MicroPort MedBot Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$17.12, shares in Shanghai MicroPort MedBot Co had a market capitalisation of HK$16.98bn.
Here are the trading details for Shanghai MicroPort MedBot Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2252
Based on an overall assessment of its quality, value and momentum Shanghai MicroPort MedBot Co is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Shanghai MicroPort MedBot Co is HK$24.83. That is 45.03% above the last closing price of HK$17.12.
Analysts covering Shanghai MicroPort MedBot Co currently have a consensus Earnings Per Share (EPS) forecast of -CNY0.31 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Shanghai MicroPort MedBot Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +90.75%.
As of the last closing price of HK$17.12, shares in Shanghai MicroPort MedBot Co were trading +47.56% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Shanghai MicroPort MedBot Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$17.12.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Shanghai MicroPort MedBot Co's management team is headed by:
- Hongbin Sun - NEC
- Chao He - PRE
- Yu Liu - SVP
- Haiying Yu - SVP
- Shuxiang Li - VPR
- Liping Zhu - DHR
- Cong Fang - SEC
- Yin Shan Hui - SEC
- Chen Chen - NED
- Xin Sun - NED
- Kit Ying Lee - NID
- Minghua Li - NID
- Haisong Yao - NID